Patrick Lloyd Tracy, MD | |
19245 7th Ave Ne, Poulsbo, WA 98370-7504 | |
(360) 782-3500 | |
Not Available |
Full Name | Patrick Lloyd Tracy |
---|---|
Gender | Male |
Speciality | Family Medicine |
Location | 19245 7th Ave Ne, Poulsbo, Washington |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1073541587 | NPI | - | NPPES |
080046467 | Other | RAILROAD MEDICARE | |
5924017 | Other | AETNA | |
49127 | Other | WA | LABOR & INDUSTRIES |
TR0082 | Other | REGENCE BLUESHIELD | |
8150674 | Medicaid | WA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | MD00017724 (Washington) | Primary |
Mailing Address | Practice Location Address |
---|---|
Patrick Lloyd Tracy, MD 2512 Wheaton Way, Bremerton, WA 98310-3399 Ph: () - | Patrick Lloyd Tracy, MD 19245 7th Ave Ne, Poulsbo, WA 98370-7504 Ph: (360) 782-3500 |
News Archive
Two new studies published in the August issue of The Journal of Nuclear Medicine (JNM) provide insight into the potential of positron emission tomography (PET) to differentiate between types of dementia and to identify pharmaceuticals to slow the progress of dementia. With proposed National Institute on Aging (NIA) and the Alzheimer's Association guidelines for detecting Alzheimer's-related brain changes expected in September, these articles give a preview of what may be to come.
People who suffer cardiac arrests and then receive coronary angiography are twice as likely to survive without significant brain damage compared with those who don't have the procedure, according to a study by University of Pittsburgh School of Medicine researchers.
Surgeons who have been advising their patients to avoid taking aspirin in the days before surgery because they feared it could cause bleeding, will be reassured by the results of a new study.
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has accepted for standard review the Company's supplemental Biologics License Application (sBLA) for EYLEA® (aflibercept) Injection for the treatment of Macular Edema following Branch Retinal Vein Occlusion (BRVO).
A natural yellowing of the eye lens that absorbs blue light has been linked to sleep disorders in a group of test volunteers, according to a study in the September 1 issue of the journal Sleep. As this type of lens discoloration worsened with age, so did the risk of insomnia.
› Verified 6 days ago
Ellen K Stehouwer, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 20730 Bond Rd Ne Ste 104, Poulsbo, WA 98370 Phone: 360-626-1166 | |
Kenneth R. Fabert, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 19379 7th Ave Ne, Poulsbo, WA 98370 Phone: 360-394-1000 | |
Dr. Mark C Hoffman, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 22180 Olympic College Way, Suite 201, Poulsbo, WA 98370 Phone: 360-394-3500 Fax: 360-394-3501 | |
Dr. Craig Duncan Karr, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 19245 7th Ave Ne, Poulsbo, WA 98370 Phone: 360-782-3500 | |
Gabriela Cash, MD, MBA Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 19980 10th Ave Ne Ste 202, Poulsbo, WA 98370 Phone: 360-979-0569 Fax: 877-805-9505 | |
Nobuhiko Kira, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 19917 7th Ave Ne Ste 205, Poulsbo, WA 98370 Phone: 360-779-1963 Fax: 360-779-6449 |